Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Gahan

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The Review of Scientific Instruments|December 3, 2015
Ion angle distribution measurement with a planar retarding field analyzerShailesh Sharma, David Gahan, Paul Scullin, et al.
The Review of Scientific Instruments|May 2, 2016
Measurement of deposition rate and ion energy distribution in a pulsed dc magnetron sputtering system using a retarding field analyzer with embedded quartz crystal microbalanceShailesh Sharma, David Gahan, Paul Scullin, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 19, 2018
Successful implementation of an automated electronic support system for patient safety monitoring: The alemtuzumab in multiple sclerosis safety systems (AMS3) studyStephen W Reddel, Michael H Barnett, Sean Riminton, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The Review of Scientific Instruments|December 3, 2015
Ion angle distribution measurement with a planar retarding field analyzerShailesh Sharma, David Gahan, Paul Scullin, et al.
The Review of Scientific Instruments|May 2, 2016
Measurement of deposition rate and ion energy distribution in a pulsed dc magnetron sputtering system using a retarding field analyzer with embedded quartz crystal microbalanceShailesh Sharma, David Gahan, Paul Scullin, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 19, 2018
Successful implementation of an automated electronic support system for patient safety monitoring: The alemtuzumab in multiple sclerosis safety systems (AMS3) studyStephen W Reddel, Michael H Barnett, Sean Riminton, et al.
Pageof 1